Codiak Biosciences Competitors and Similar CompaniesClear all
Takeda's competitors and similar companies include AstraZeneca and ArunA Bio.
 Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | |
Founding Date | Founding Date 1781 | Founding Date 1999 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Athens, US HQ Athens, US | |
Employees | Employees 47,4554% decrease | Employees 94,300 | Employees 274% increase |
Valuation ($) | Valuation ($) 43.7 b | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥3.8t (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ¥108.1b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 57.8m | Total funding raised $ 1b | Total funding raised $ 26.9m |
For sources of this data, please see the company profile
View Company Profiles
AstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company